AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

IRLAB Therapeutics

Major Shareholding Notification Dec 30, 2020

3062_iss_2020-12-30_3981f8f4-c96d-4d58-9f19-d5f9d56f06cf.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer IRLAB Therapeutics AB

Holder

Fjärde AP-fonden

Instrument

Instrument Aktie
Before the transaction
Shares 2,419,366
Voting rights 2,419,366
Transaction
Date 30/12/2020
Limit for number of shares 5 %
Limit for number of votes 5 %

After the transaction

Quantity

Shares 3,044,366
Directly held voting rights 3,044,366
Indirectly held voting rights 0

Percentage

Directly held shares 5.88 % Directly held voting rights 5.88 % Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.88 % 3,044,366
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.88 % 3,044,366
Group
total
holdings
Voting rights
3,044,366
Percentage of voting rights 5.88
Published
30/12/2020 20:39
Contact
Name
Jannis Kitsakis
Phone
070-6038023 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.